Exercise and Happiness

A big, consistent body of evidence

In 2023, researchers pulled together 97 reviews covering 1,039 trials and about 128,000 adults. Exercise reduced depression, anxiety and psychological distress by a moderate amount compared with usual care. Programmes with harder effort showed bigger benefits.

For people with diagnosed depression, a 2024 analysis of 218 trials found that walking or jogging, yoga, strength training and tai chi all helped. Yoga and strength training were the easiest for people to stick with.

Walking counts: it was one of the most effective activities in trials for depression. Photo: National Cancer Institute, public domain, via Wikimedia Commons.

Honest about the size

The 2026 Cochrane review, one of the most careful assessments, found a moderate benefit overall. When it looked only at the most rigorous trials, the benefit was smaller but still present. Because people always know whether they are exercising, these trials cannot be fully "blind", which may inflate results a little. The fair summary: exercise helps, probably by a small-to-moderate amount.

Small amounts matter most

A study of about 191,000 adults found that people doing half the recommended amount of activity had about 18% lower risk of depression. Doing the full recommended amount (about 2.5 hours of brisk walking a week) brought 25% lower risk. Doing even more added little. This was an observational study, so it shows a strong link rather than proof, but a separate genetic study also suggests activity protects against depression.

More than just less misery

In healthy people, physical activity is linked mainly with more positive feelings such as energy and enjoyment, rather than with fewer negative ones. A review of 103 studies found that a single session improved mood within 30 minutes.

Young people

A 2026 review of 375 trials in people aged 5 to 18 found exercise programmes reduced depression and anxiety by a moderate amount. Moderate-intensity and mixed activities worked best for depression, and strength training for anxiety. School activity programmes also improved wellbeing and resilience.

Is exercise as good as therapy or medication?

The 2026 Cochrane review found little or no difference between exercise and talking therapy, and probably little difference between exercise and antidepressants, although those comparisons rest on fewer and smaller trials. Side effects were uncommon: mainly minor injuries with exercise, compared with digestive upset, sexual side effects and tiredness with the antidepressant studied (sertraline). Guidelines now reflect this. In the UK, NICE lists group exercise among the first-line treatments for less severe depression in adults, and Canada's 2023 CANMAT guideline recommends a supervised exercise programme on its own as a first-line treatment for mild depression. The guidelines back a structured programme, typically three or so sessions a week for at least two to three months, rather than vague advice to move more.

If low mood is severe, lasts for weeks, or comes with thoughts of self-harm, talk to a doctor or a trusted adult.

What this means for you

Start small, choose something you like, and build up. For mild low mood, a regular exercise routine can be the treatment in its own right.

Adult efficacy

• Umbrella review. Singh et al. (2023): 97 meta-analyses, 1,039 RCTs, N = 128,119. Median effects: depression SMD -0.43, anxiety -0.42, psychological distress -0.60. Higher intensity was associated with larger effects; longer programmes with smaller ones. Note that 77 of 97 included reviews were rated critically low quality by AMSTAR-2.
• Network meta-analysis. Noetel et al. (2024): 218 RCTs, N = 14,170 adults with major depression. Against active controls: walking/jogging g = -0.62, yoga -0.55, strength training -0.49, mixed aerobic -0.43, tai chi/qigong -0.42. Effects scaled with prescribed intensity. Only one trial was at low risk of bias; certainty was mostly low or very low. Funded trials reported larger effects than unfunded ones.
• Cochrane. Clegg et al. (2026): 73 RCTs. SMD -0.67 versus control (low certainty), attenuating to -0.46 in the seven trials with adequate allocation concealment, intention-to-treat analysis and blinded outcome assessment. Long-term effects very uncertain. Exercise versus psychological therapy: little or no difference (moderate certainty; 10 trials). Versus pharmacotherapy: little or no difference (low certainty; 5 trials). All trials carried high performance-bias risk.
• Resistance training. Gordon et al. (2018): 33 RCTs, N = 1,877; benefit independent of total volume and strength gains; smaller effects in blinded trials.
• Anxiety. Aylett et al. (2018): 15 RCTs, N = 675; aerobic exercise versus waitlist SMD -0.41; high intensity outperformed low.

Dose-response and causality

Pearce et al. (2022): 15 prospective cohorts, N = 191,130. Curvilinear association; half the guideline volume associated with 18% lower depression risk, full guideline with 25%, little additional benefit beyond. Activity was self-reported; I² = 74%. Choi et al. (2019) used two-sample Mendelian randomisation: accelerometer-measured activity was protective (OR 0.74 per SD), self-reported activity was not, and there was no evidence of reverse causation from depression to activity.

Positive wellbeing and acute effects

Buecker et al. (2021) found a positive association between physical activity and subjective wellbeing in healthy populations (pooled 0.36), driven by positive affect, with no association with negative affect; effects appeared in experimental as well as correlational designs, with large heterogeneity. Weinstein et al. (2024): 103 studies, N = 4,671; single bouts improved mood (g = 0.34), anxiety (g = 0.50) and depressive feelings (g = 0.41) within 30 minutes; mostly within-person pre/post designs.

Children and adolescents

Singh et al. (2026): 21 reviews, 375 RCTs, N = 38,117, ages 5 to 18. Depression SMD -0.45 (moderate certainty), anxiety SMD -0.39 (low to moderate). Mixed-mode and moderate-intensity activity best for depression; resistance best for anxiety; programmes under 12 weeks performed better. An accompanying editorial notes the confidence intervals span very small to medium effects (Cortese et al., 2026). Recchia et al. (2023) found a smaller post-intervention effect (g = -0.29; 21 trials) and no clear follow-up effect. School-related programmes improved wellbeing (g = 0.88) and resilience (g = 0.75), with high heterogeneity and weaker effects for wide-reach programmes (Andermo et al., 2020). In the ALSPAC cohort, each additional daily hour of accelerometer-measured sedentary time from ages 12 to 16 was associated with 8 to 11% higher depression scores at 18, and each hour of light activity with 8 to 11% lower scores (Kandola et al., 2020; observational, screen time not adjusted).

Guidelines

WHO (Bull et al., 2020): adults 150 to 300 minutes of moderate or 75 to 150 minutes of vigorous activity weekly, plus muscle strengthening twice weekly; young people an average of 60 minutes daily of moderate-to-vigorous activity. No sedentary threshold was set. These guidelines target broad health outcomes, not mental health specifically.

Clinical guidelines

NICE NG222 (2022) lists group exercise among the first-line options for less severe depression in adults (Table 1) and advises against routinely offering antidepressants first line in less severe depression unless the person prefers them (recommendation 1.5.3); for more severe depression it remains an option, with higher-contact treatments to be considered first (1.6.1). CANMAT 2023 recommends supervised exercise (low to moderate intensity, 30 to 40 minutes, three to four times weekly, at least nine weeks) as first-line monotherapy for mild depression and second-line adjunct for moderate depression (Lam et al., 2024). Both guidelines support structured programmes rather than general activity advice, and neither supports lifestyle change alone for severe depression or where there is risk of self-harm. For young people, NICE NG134 does not list exercise as a treatment for mild depression. Noetel et al. (2024) report that funded trials showed larger effects than unfunded ones; this concerns any funding, not specifically industry funding, but it suggests some inflation of pooled effects.

Open debates

True effect size under blinding constraints and expectancy; poor quality of many included reviews; intensity (higher in adults, moderate in youth); why shorter programmes outperform longer ones; measurement-dependent causal signals; attenuation at scale; whether nature adds anything beyond the exercise itself (Lahart et al., 2019, found limited low-quality evidence).

Claims we deliberately do not make

That exercise "beats" antidepressants; that it cures depression; that more is always better; that endorphins explain the effect (no source reviewed tests mechanisms); precise "magic numbers" drawn from cross-sectional surveys; that green exercise is far superior; that screens cause teen depression.